Fails 2 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The product pages, footer and terms refer only to partner compounding pharmacies in the United States and state-licensed compounding pharmacies. 1 more criterion also fails; see the table below.
At a glance
Superior RemediesTelehealth service
6/8criteria passed
Price
Compounded semaglutide from $149 a month, a limited time offer for new patients with no later price printed; tirzepatide from $249
Sells
compounded semaglutide, compounded tirzepatide, GLP-1 microdose, and 1 more
Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.
A telehealth platform selling compounded semaglutide, tirzepatide and a lower-dose GLP-1 microdose program at flat monthly prices, plus NAD+, with care from independent providers after a short online quiz. It says treatment charges are processed only once a provider approves the patient.
The evidence behind each disposition in the table above, where it appears, and its date.
S1PASSA licensed clinician reviews each online assessment and creates a plan only if treatment is clinically appropriate, and the footer says every evaluation and prescription decision is made by independent U.S. board-certified practitioners. No prescriber is named.Source: Superior Remedies' website; Superior Remedies' semaglutide product page.
S2PASSThe steps are a two-minute quiz about goals and health, then a provider's review, then delivery. The home page says a patient pays only once cleared, and the footer says treatment charges are not processed if the patient is not medically approved.Source: Superior Remedies' website; Superior Remedies' about page.
S3FAILNo filling pharmacy is named. The product pages, footer and terms refer only to partner compounding pharmacies in the United States and state-licensed compounding pharmacies.Source: Superior Remedies' semaglutide product page; Superior Remedies' terms; Superior Remedies' website.
S4PASSThe footer on every page and the peptide page state that compounded medications are not FDA-approved, and the product pages list compounded medication as part of each program.Source: Superior Remedies' website; Superior Remedies' peptides page; Superior Remedies' semaglutide product page.
S5FAILNo certificate of analysis or lot document is published on the product pages, the peptide page or the terms.Source: Superior Remedies' semaglutide product page; Superior Remedies' peptides page; Superior Remedies' terms.
S6PASSSuperior Remedies LLC at 19150 Bay Meadows Drive, Apple Valley, CA 92308, printed on the contact page. The terms and privacy policy print the same street and ZIP code with WI as the state, and the terms name Delaware law.Source: Superior Remedies' contact page; Superior Remedies' terms; Superior Remedies' privacy page.
S7PASSThe home page prints $149 a month for the program as a limited time offer for new patients, with no later price printed. The peptide page lists semaglutide injection and the GLP-1 microdose from $149 a month, tirzepatide injection from $249 a month and NAD+ from $199 a month, and the product pages describe flat-rate pricing with no consultation charge.Source: Superior Remedies' website; Superior Remedies' peptides page; Superior Remedies' semaglutide product page.
S8PASSNo FDA warning letter names Superior Remedies or Superior Remedies LLC, and no action has halted the business.Source: FDA warning-letter index.
Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, GLP-1 microdose, NAD+.
Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.